Seattle, WA (PRWEB) June 05, 2014
Quorum Review IRB, the industry leader in central IRB services, announces Mitchell E. Parrish, JD, RAC, CIP, as a presenter at DIA’s 50th Annual Meeting. The event takes place June 15-19, 2014 at the San Diego Convention Center in San Diego, California.
Mr. Parrish speaks on the topic of Research Consent in Acute Settings at 10:30 AM on June 17, 2014. The presentation focuses on the inherent obstacles of this type of research, as well as concrete ways to obtain effective consent while concurrently respecting the research participant, study design, and enrollment numbers. Quorum Review’s Business Development Team will also be present in the exhibition hall at Booth #2030 during the conference dates.
Mr. Parrish is a Regulatory Attorney for Quorum Review, where he provides legal counsel on U.S. and Canadian laws and regulations related to medical product research and development. Mr. Parrish is a member of the Regulatory Affairs Professionals Society, Public Responsibility in Medicine & Research, Association of Corporate Counsel, and Washington State Bar Association. He also has his Regulatory Affairs Certification (RAC) and is a Certified IRB Professional (CIP). Prior to Quorum, Mr. Parrish served as a Regulatory Consultant to the National Cancer Institute.
DIA’s Annual Meeting is the nation’s largest multidisciplinary event bringing together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development, and life cycle management of medical products. These professionals share a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 15 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, international ethics review, a specialized Phase I team, and unique processes for minimal risk research.